Overview
Lobbying Costs
None declared
None declared
Lobbyists (Full time equivalent)
0.75 Fte (2)
Lobbyists with EP accreditation
1
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Sandoz International GmbH
EU Transparency Register
111463951460-07 First registered on 12 Oct 2023
Goals / Remit
Our Purpose at Sandoz is clear: pioneering access for patients. Our Purpose shines through in our rich heritage, as in our plans for the future. Our Vision is to be the world’s leading and most valued generics and biosimilars company. We aim to be valued for how we run our business, but also for the positive impact we have on society. That’s how we will deliver sustainably on our Purpose.
Main EU files targeted
Antimicrobial Resistance, EU Pharmaceutical Legislation, EU Pharmaceutical Strategy, F-Gas Regulation, Industrial Strategy, IP Action Plan, Orphan Medicines Regulation, Pediatric Medicines, Pharmaceutical Pricing, Waste Water Treatment Directive
Address
Head Office
Industriestr. 25
Holzkirchen 83607
GERMANYEU Office
Industriestr. 25
Holzkirchen 83607
GERMANYWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 50% 1 25% 1 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 27 Jul 2024
Name Start date End Date Arnaud MAHÉAS 29 Feb 2024 28 Feb 2025 Complementary Information
In 2023, 1 associate in Brussels spends 50% of working time on activities falling within the scope of the register.
1 associate at Europe headquarters spends up to 25% of working time on activities falling within the scope of the register.
Other associates involved on activities falling within the scope of the register spent less than 10% of their time on such activities.Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Medicines for Europe (including Biosimilar Medicines Sector Group and VAM Sector Group)
European Healthcare Distribution Association (GIRP)
ACIP (CEFIC Sector Group)Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
None declared
Lobbying costs for closed financial year
None declared
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
None declared
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None
Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 07 Jun 2024 Location Kundl, Austria Subject Strategic autonomy and current developments in the medical/pharmaceutical sector Cabinet Cabinet of Commissioner Johannes Hahn Attending - Johannes Hahn (Commissioner)